| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure.
|
Am J Med
|
1997
|
3.91
|
|
2
|
The use of biochemical markers of bone turnover in osteoporosis. Committee of Scientific Advisors of the International Osteoporosis Foundation.
|
Osteoporos Int
|
2000
|
2.14
|
|
3
|
Models of care for the secondary prevention of osteoporotic fractures: a systematic review and meta-analysis.
|
Osteoporos Int
|
2012
|
1.80
|
|
4
|
Circaannual rhythms and interactions of vitamin D metabolites, parathyroid hormone, and biochemical markers of skeletal homeostasis: a prospective study.
|
J Bone Miner Res
|
2000
|
1.66
|
|
5
|
Comparison of total and bone-specific alkaline phosphatase in patients with nonskeletal disorder or metabolic bone diseases.
|
Clin Chem
|
1996
|
1.45
|
|
6
|
Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.
|
J Clin Endocrinol Metab
|
2001
|
1.42
|
|
7
|
Evaluation of urinary hydroxypyridinium crosslink measurements as resorption markers in metabolic bone diseases.
|
Eur J Clin Invest
|
1991
|
1.28
|
|
8
|
Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxy vitamin d status, bone mass, and renal function in the frail and very old: a cohort study.
|
J Clin Endocrinol Metab
|
2004
|
1.25
|
|
9
|
Seasonal variation of biochemical indexes of bone turnover: results of a population-based study.
|
J Clin Endocrinol Metab
|
1998
|
1.17
|
|
10
|
Targeted intervention reduces refracture rates in patients with incident non-vertebral osteoporotic fractures: a 4-year prospective controlled study.
|
Osteoporos Int
|
2010
|
1.12
|
|
11
|
Influence of fall related factors and bone strength on fracture risk in the frail elderly.
|
Osteoporos Int
|
2007
|
1.11
|
|
12
|
Serum bone sialoprotein in patients with primary breast cancer is a prognostic marker for subsequent bone metastasis.
|
Clin Cancer Res
|
1999
|
1.10
|
|
13
|
Looking beyond low bone mineral density: multiple insufficiency fractures in a woman with post-menopausal osteoporosis on alendronate therapy.
|
J Endocrinol Invest
|
2007
|
1.09
|
|
14
|
Direct, enzyme-linked immunoassay for urinary deoxypyridinoline as a specific marker for measuring bone resorption.
|
J Bone Miner Res
|
1994
|
1.07
|
|
15
|
Changes in bone turnover induced by aerobic and anaerobic exercise in young males.
|
J Bone Miner Res
|
1998
|
1.06
|
|
16
|
Case-control analysis of bone resorption markers, disability, and hip fracture risk: the Rotterdam study.
|
BMJ
|
1996
|
1.05
|
|
17
|
Effects of a multi-component exercise program and calcium-vitamin-D3-fortified milk on bone mineral density in older men: a randomised controlled trial.
|
Osteoporos Int
|
2008
|
1.03
|
|
18
|
Serum parathyroid hormone predicts time to fall independent of vitamin D status in a frail elderly population.
|
J Clin Endocrinol Metab
|
2004
|
1.03
|
|
19
|
Statistical genetic analysis of plasma levels of vitamin D: familial study.
|
Ann Hum Genet
|
1999
|
1.02
|
|
20
|
Biochemical markers of bone formation in patients with plasma cell dyscrasias and benign osteoporosis.
|
Clin Chem
|
2001
|
1.00
|
|
21
|
Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
|
J Bone Miner Res
|
1999
|
0.99
|
|
22
|
Bone loss and turnover after cardiac transplantation.
|
J Clin Endocrinol Metab
|
1997
|
0.99
|
|
23
|
Lower serum 25-hydroxyvitamin D is associated with increased bone resorption markers and lower bone density at the proximal femur in normal females: a population-based study.
|
Exp Clin Endocrinol Diabetes
|
1996
|
0.99
|
|
24
|
Serum tartrate-resistant acid phosphatase 5b is a specific and sensitive marker of bone resorption.
|
Clin Chem
|
2001
|
0.98
|
|
25
|
Biochemical markers of bone turnover reflect femoral bone loss in elderly women.
|
Calcif Tissue Int
|
1996
|
0.96
|
|
26
|
The diagnostic value of urinary pyridinium cross-links of collagen, serum total alkaline phosphatase, and urinary calcium excretion in neoplastic bone disease.
|
J Clin Endocrinol Metab
|
1995
|
0.94
|
|
27
|
Oral bisphosphonates are associated with reduced mortality in frail older people: a prospective five-year study.
|
Osteoporos Int
|
2010
|
0.94
|
|
28
|
Bone resorption in multiple myeloma and in monoclonal gammopathy of undetermined significance: quantification by urinary pyridinium cross-links of collagen.
|
Blood
|
1997
|
0.92
|
|
29
|
Does increased sunlight exposure work as a strategy to improve vitamin D status in the elderly: a cluster randomised controlled trial.
|
Osteoporos Int
|
2011
|
0.91
|
|
30
|
Rapid biochemical response to denosumab in fibrous dysplasia of bone: report of two cases.
|
Osteoporos Int
|
2013
|
0.90
|
|
31
|
Prevention of bone loss after heart transplantation with antiresorptive therapy: a pilot study.
|
J Heart Lung Transplant
|
1998
|
0.89
|
|
32
|
Cost-effectiveness of the Concord Minimal Trauma Fracture Liaison service, a prospective, controlled fracture prevention study.
|
Osteoporos Int
|
2011
|
0.89
|
|
33
|
Dehydroepiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandrosterone secretion.
|
J Clin Endocrinol Metab
|
2001
|
0.87
|
|
34
|
Osteoporosis in eating disorders: a follow-up study of patients with anorexia and bulimia nervosa.
|
J Clin Endocrinol Metab
|
2001
|
0.87
|
|
35
|
Biochemical markers of bone remodeling and bone sialoprotein in ankylosing spondylitis.
|
Clin Chim Acta
|
1999
|
0.86
|
|
36
|
Serum bone sialoprotein as a marker of tumour burden and neoplastic bone involvement and as a prognostic factor in multiple myeloma.
|
Br J Cancer
|
2001
|
0.86
|
|
37
|
Lifestyle factors, medications, and disease influence bone mineral density in older men: findings from the CHAMP study.
|
Osteoporos Int
|
2010
|
0.86
|
|
38
|
Comparison of serum and urine assays for biochemical markers of bone resorption in postmenopausal women with and without hormone replacement therapy and in men.
|
Osteoporos Int
|
2000
|
0.84
|
|
39
|
Thyrotropin-releasing hormone secretory physiology: studies by radioimmunoassay and affinity chromatography.
|
Endocrinology
|
1975
|
0.83
|
|
40
|
Socioeconomic status and bone health in community-dwelling older men: the CHAMP Study.
|
Osteoporos Int
|
2010
|
0.82
|
|
41
|
Improved purification of human bone sialoprotein and development of a homologous radioimmunoassay.
|
Clin Chem
|
1997
|
0.82
|
|
42
|
Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes.
|
J Clin Endocrinol Metab
|
2006
|
0.82
|
|
43
|
Urinary pyridinium cross-link excretion is increased in critically ill surgical patients.
|
Crit Care Med
|
1997
|
0.82
|
|
44
|
Short- and long-term effects of ibandronate treatment on bone turnover in Paget disease of bone.
|
Clin Chem
|
2000
|
0.82
|
|
45
|
Biochemical markers of osteoarthritis.
|
Curr Opin Rheumatol
|
1990
|
0.81
|
|
46
|
Fracture after cardiac transplantation: a prospective longitudinal study.
|
J Clin Endocrinol Metab
|
1996
|
0.81
|
|
47
|
Predictors of re-fracture amongst patients managed within a secondary fracture prevention program: a 7-year prospective study.
|
Osteoporos Int
|
2014
|
0.81
|
|
48
|
Relationship between indices of adiposity obtained by peripheral quantitative computed tomography and dual-energy X-ray absorptiometry in pre-pubertal children.
|
Ann Hum Biol
|
2009
|
0.80
|
|
49
|
Dehydroepiandrosterone replacement in women with adrenal insufficiency: effects on body composition, serum leptin, bone turnover, and exercise capacity.
|
J Clin Endocrinol Metab
|
2001
|
0.80
|
|
50
|
Compliance and persistence to oral bisphosphonate therapy following initiation within a secondary fracture prevention program: a randomised controlled trial of specialist vs. non-specialist management.
|
Osteoporos Int
|
2014
|
0.79
|
|
51
|
Predictors of the rate of BMD loss in older men: findings from the CHAMP study.
|
Osteoporos Int
|
2012
|
0.79
|
|
52
|
Influence of ovariectomy and estradiol treatment on calcium homeostasis during aging in rats.
|
Arch Physiol Biochem
|
1997
|
0.79
|
|
53
|
Vitamin D status among older community dwelling men living in a sunny country and associations with lifestyle factors: the Concord Health and Ageing in Men Project, Sydney, Australia.
|
J Nutr Health Aging
|
2013
|
0.79
|
|
54
|
Urinary excretion of galactosyl-hydroxylysine is a marker of growth in children.
|
J Clin Endocrinol Metab
|
1995
|
0.78
|
|
55
|
Synthesis and preclinical pharmacology of 2-(2-aminopyrimidinio) ethylidene-1,1-bisphosphonic acid betaine (ISA-13-1)-a novel bisphosphonate.
|
Pharm Res
|
1999
|
0.78
|
|
56
|
The effects of bed-rest and countermeasure exercise on the endocrine system in male adults: evidence for immobilization-induced reduction in sex hormone-binding globulin levels.
|
J Endocrinol Invest
|
2011
|
0.78
|
|
57
|
Risk assessment for osteoporosis. II. Biochemical markers of bone turnover: bone resorption indices.
|
Clin Lab Med
|
2000
|
0.78
|
|
58
|
[Quantitative detection of keratan sulfate specific epitopes in synovial fluid in inflammatory and degenerative joint diseases].
|
Z Rheumatol
|
1990
|
0.77
|
|
59
|
Thyrotropin releasing hormone interactions with an anterior pituitary membrane receptor.
|
Endocrinology
|
1973
|
0.77
|
|
60
|
Octreotide (somatostatin analog) treatment reduces endothelial cell dysfunction in patients with diabetes mellitus.
|
Metabolism
|
1999
|
0.77
|
|
61
|
Biochemical markers of bone metabolism.
|
Z Rheumatol
|
1991
|
0.77
|
|
62
|
Molecular markers of bone and cartilage metabolism.
|
Curr Opin Rheumatol
|
1999
|
0.77
|
|
63
|
Bone turnover 18 months after a single intravenous dose of zoledronic acid.
|
Int J Clin Pract
|
2007
|
0.77
|
|
64
|
Free deoxypyridinoline in urine and serum--results in children and adolescents.
|
Exp Clin Endocrinol Diabetes
|
1996
|
0.77
|
|
65
|
Urinary immunoreactive deoxypyridinoline in children and adolescents: variations with age, sex and growth velocity.
|
Scand J Clin Lab Invest
|
1996
|
0.76
|
|
66
|
Serum undercarboxylated osteocalcin and the risk of hip fracture.
|
J Clin Endocrinol Metab
|
1997
|
0.76
|
|
67
|
The effect of intranasal salmon calcitonin on postmenopausal bone turnover as assessed by biochemical markers: evidence of maximal effect after 8 weeks of continuous treatment.
|
Calcif Tissue Int
|
1996
|
0.76
|
|
68
|
Association between histomorphometry and biochemical markers of bone turnover in a longitudinal rat model of parathyroid hormone-related peptide (PTHrP)-mediated tumor osteolysis.
|
Bone
|
2000
|
0.76
|
|
69
|
Intrusive pain and worry about health in older men: the CHAMP study.
|
Pain
|
2010
|
0.76
|
|
70
|
Calcaneal ultrasound but not bone turnover predicts fractures in vitamin D deficient frail elderly at high risk of falls.
|
Calcif Tissue Int
|
2006
|
0.76
|
|
71
|
Are levels of bone turnover related to lower bone mass of adolescents previously fed a macrobiotic diet?
|
Exp Clin Endocrinol Diabetes
|
2001
|
0.76
|
|
72
|
Biochemical markers to survey bone turnover.
|
Rheum Dis Clin North Am
|
2001
|
0.75
|
|
73
|
Add-back medrogestone does not prevent bone loss in premenopausal women treated with goserelin.
|
Exp Clin Endocrinol Diabetes
|
1999
|
0.75
|
|
74
|
The effect of pramlintide (amylin analogue) treatment on bone metabolism and bone density in patients with type 1 diabetes mellitus.
|
Horm Metab Res
|
1999
|
0.75
|
|
75
|
Erythropoietin administration does not influence the GH--IGF axis or makers of bone turnover in recreational athletes.
|
Clin Endocrinol (Oxf)
|
2005
|
0.75
|
|
76
|
Age-related changes and secular trends in hand bone size.
|
Homo
|
2008
|
0.75
|
|
77
|
Low dose estrogen and calcium have an additive effect on bone resorption in older women.
|
J Clin Endocrinol Metab
|
1999
|
0.75
|
|
78
|
[Female pseudohermaphroditism in congenital adrenogenital syndrome as an incidental intraoperative finding in a 68 year old patient].
|
Dtsch Med Wochenschr
|
2000
|
0.75
|
|
79
|
Epiphyseal expansion in hand bones: association with age, sex, and hand osteoarthritis.
|
Osteoarthritis Cartilage
|
2007
|
0.75
|
|
80
|
Urinary free deoxypyridinoline by chemiluminescence immunoassay: analytical and clinical evaluation.
|
Clin Chem
|
1998
|
0.75
|
|
81
|
Influence of aging on cortical and trabecular bone response to estradiol treatment in ovariectomized rats.
|
Gerontology
|
1998
|
0.75
|
|
82
|
[Systemic lupus erythematosus as a contraindication for estrogen treatment].
|
Hautarzt
|
1994
|
0.75
|
|
83
|
Effects of glucose, insulin and adrenalin on glycerol metabolism in adipose tissue from hypothyroid rats.
|
Mol Cell Endocrinol
|
1978
|
0.75
|
|
84
|
Influence of ovariectomy on bone metabolism in very old rats.
|
Calcif Tissue Int
|
1996
|
0.75
|
|
85
|
[Hyaluronic acid and N-terminal procollagen-III-peptide in the urine in inflammatory and degenerative joint diseases].
|
Z Rheumatol
|
1989
|
0.75
|
|
86
|
[Bilateral, large cavitary broncho-alveolar carcinoma of a diffuse type].
|
Prax Klin Pneumol
|
1987
|
0.75
|
|
87
|
[Measurement of keratan sulfate levels in synovial fluid in joint diseases].
|
Vnitr Lek
|
1989
|
0.75
|
|
88
|
Metabolic response to short periods of starvation in hypo- and hyper-thyroid male rats.
|
Horm Metab Res
|
1978
|
0.75
|